Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2004
02/12/2004WO2003050502A3 Prospective identification and characterization of breast cancer stem cells
02/12/2004WO2003050301A3 Susceptibility locus for schizophrenia
02/12/2004WO2003039485A3 Stable liquid pharmaceutical formulation of igg antibodies
02/12/2004WO2003039346A3 Diagnostics and therapeutics for ocular abnormalities
02/12/2004WO2003033670A3 Method for preparation of single chain antibodies
02/12/2004WO2003033653B1 Affinity enhancement agents
02/12/2004WO2003016470A3 Enhancing the efficacy of immunotherapies by supplementing with complement
02/12/2004WO2003010282A3 Interleukin-1 beta antibodies
02/12/2004WO2002100330A3 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
02/12/2004WO2002095051A3 Mage-a3 peptides presented by hla class ii molecules
02/12/2004WO2002090542A8 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof
02/12/2004WO2002077232A3 Compositions and methods relating to breast specific genes and proteins
02/12/2004WO2002068461A3 Heterocarpine, a human ghrh-binding protein
02/12/2004WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same
02/12/2004WO2002066063A8 Remedies for metabolic bone diseases
02/12/2004WO2002059609A3 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators
02/12/2004WO2002059299A3 Expression cloning method
02/12/2004WO2002057454A3 Receptors and membrane-associated proteins
02/12/2004WO2002057411A3 Hydrolase enzymes and their use in kinetic resolution
02/12/2004WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
02/12/2004WO2002046411A3 Intestinal proteins
02/12/2004WO2002035981A3 Methods and compositions for the treatment of human immunodeficiency virus infection
02/12/2004US20040031073 Method for modifying plant morphology, biochemistry and physiology
02/12/2004US20040030115 Nucleic acids containing the coding regions of the genes encoding such proteins, vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins; useful for diagnosing and treating disorders related to them
02/12/2004US20040030112 Use of these kinases as targets for isolating specific inhibitors or antagonists of the kinase activity, the inhibitors are anticipated to have use as contraceptive agents
02/12/2004US20040030106 Novel compounds and process
02/12/2004US20040030103 Anti-idiotype inducing antibodies, comprising at least one epitope from angiodenin, for the inhibition of angiogenesis
02/12/2004US20040029775 Methods and compounds for influencing beta3-integrin-dependent intracellular processes
02/12/2004US20040029280 Viral vectors with modified tropism
02/12/2004US20040029268 Endothelialization of vascular surfaces
02/12/2004US20040029246 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
02/12/2004US20040029234 Enhanced 2-keto-l-gulonic acid production
02/12/2004US20040029232 Novel G-protein coupled receptors
02/12/2004US20040029228 Cytokine receptor
02/12/2004US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals
02/12/2004US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/12/2004US20040029197 Novel human cancer/testis antigen and gene thereof
02/12/2004US20040029169 Nogo Receptor (NgR)-p75; myelins; for drug screening; cell-free
02/12/2004US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
02/12/2004US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
02/12/2004US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders
02/12/2004US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments
02/12/2004US20040029115 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously
02/12/2004US20040029113 Cleaving single-stranded nucleic acid sequences by contacting with a oligonucleotide; restriction endonuclease recognition site; fab fragments
02/12/2004US20040028700 Antigenic proteins of shrimp white spot syndrome virus and uses thereof
02/12/2004US20040028687 Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues
02/12/2004US20040028685 EphA2 monoclonal antibodies and methods of use thereof
02/12/2004US20040028684 Cancer diagnosis and assays for screening anti-cancer agents
02/12/2004US20040028682 Inhibiting transforming growth factor beta to prevent accumulation of extracellular matrix
02/12/2004US20040028681 Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist
02/12/2004US20040028680 Complexing fibroblast growth factor ; controlling elimination from cell
02/12/2004US20040028677 Chimeric allograft tolerance induction, monitoring and maintenance
02/12/2004US20040028669 Human gene critical to fertility
02/12/2004US20040028667 Mixture containing probiotic bacteria; stability
02/12/2004US20040028648 Administering integrins; prevent tissue swelling
02/12/2004US20040027537 Continuous two-dimensional corneal topography target
02/12/2004DE10234116A1 Preparation of recombinant single-chain Fv fragments in plants, useful for control of plant and human viral infections, comprises using an expression vector
02/12/2004CA2505849A1 Novel tricistronic vectors and uses therefor
02/12/2004CA2494310A1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
02/12/2004CA2494121A1 Modulation of mesenchymal cells via iga-receptors
02/12/2004CA2494115A1 Mutants of ige proteins and uses thereof
02/12/2004CA2492457A1 Antibodies against c3a receptor
02/12/2004CA2487528A1 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
02/11/2004EP1388544A1 Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof
02/11/2004EP1388543A2 Antibodies against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
02/11/2004EP1387889A2 Kinases and phosphatases
02/11/2004EP1387888A2 Nucleic acid-associated proteins
02/11/2004EP1387886A2 Proteases
02/11/2004EP1387698A2 Method of preventing cell death using antibodies to neural thread proteins
02/11/2004EP1387697A2 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
02/11/2004EP1387696A2 Anti-ige antibody to treat ocular allergies
02/11/2004EP1387674A2 Hedgehog antagonists, methods and uses related thereto
02/11/2004EP0970377B1 Diagnosis of epithelial cell abnormalities
02/11/2004EP0922225B1 Assay for quantifying arthritic conditions
02/11/2004EP0888452B1 Human cyr61, an extracellular matrix signalling molecule
02/11/2004EP0858467B1 Materials and methods relating to the identification and sequencing of the brca2 cancer susceptibility gene and uses thereof
02/11/2004EP0835124B1 Serum preparations for inhibiting retroviruses and tumor growth
02/11/2004EP0804482B1 Cytokines that bind the cell surface receptor hek
02/11/2004EP0506868B2 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine
02/11/2004CN1474872A Method for modifying plant morphology, biochemistry and physiology
02/11/2004CN1473925A Heterotrophic medium composition for transgenenic chlorella
02/11/2004CN1473854A Recombined IL4 antibody for treating IL4 insertion diseases
02/11/2004CN1473853A Anti-bacteria endotoxin chicken ritellus antibody and its preparation and its use
02/11/2004CN1473850A New human protein with mouse NIH/3T3 cell transformation improving function and its code sequence
02/11/2004CN1473849A Novel human protein with cancer inhibiting function and its code sequence
02/11/2004CN1473846A Method for producing rabbit alexin by high density heterotrophically cultivating transgenosis chlorella
02/11/2004CN1137779C Method for preparing 3,4-dichlorophenylnitrile by using ammonia oxidation process and its special purpose catalyst
02/11/2004CN1137727C Process for preparation of immune globulin for introvenous injection by dual inactivation of virus without protectives
02/11/2004CN1137726C Method of prolonged suppression of humoral immunity
02/10/2004US6689877 Administering a therapeutic amount of nebr1 antiretroviral transcriptional factor to hiv infected cells in patient
02/10/2004US6689869 Labeled humanized anti-CD18 antibodies and fragments and kits comprising same
02/10/2004US6689868 Isolated antibody which selectively binds to isolated cd2bp1 protein having specified amino acid sequence
02/10/2004US6689866 Isolated polypeptide comprising specified amino acid sequence; membrane-bound or secreted polypeptide having semaphorin-like activity
02/10/2004US6689864 Isolated polypeptide comprising cyclin dependent kinase 4 inhibitor or biologically active fragment thereof, encoded by dna molecule consisting of specified sequence
02/10/2004US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
02/10/2004US6689751 Peptide comprising amino acid sequence 15 or 83 with alanine or alpha-aminoisobutyrate substitution
02/10/2004US6689611 Modified Streptomyces host cells for increased avermectin production and methods of making the same
02/10/2004US6689598 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
02/10/2004US6689597 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
02/10/2004US6689585 GABA-B2 receptor